Research & Development
Exploiting the synergy in oncology
SILENCING UNDRUGGABLE TARGETS WITH siRNA
BS Biotechna pioneers cutting-edge drug delivery systems. Central to our core technology is the ability to design and nano-manufacture drug delivery systems capable of transporting two different molecules with varying physiochemical properties and mechanisms of action, all aimed at achieving synergistic therapeutic benefits in cancer treatment. This dual-drug delivery approach enhances the precision and efficacy of cancer therapies, addressing the complexities of tumor heterogeneity.
Our other systems demonstrate proficiency in preserving and stabilizing therapeutic nucleic acids during room temperature storage and in the bloodstream, paving the way for successful delivery of gene-based therapies. Moreover, these nanoparticles can be further modified with targeting ligands, improving accuracy of delivery directly to the tumor cells.